Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metastatic Urothelial Cancer
Clinical trial NCT03036098 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03036098
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-24
- Primary completion
- 2024-08-30
- Enrollment
- 1314
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.